Suppr超能文献

活性维生素 D 补充与 COVID-19 感染:综述。

Active vitamin D supplementation and COVID-19 infections: review.

机构信息

Nephrology and Hypertension Division, Baruch Padeh Poriya medical Center, Erlangen, Germany.

Diabetes and Metabolism Lab, Baruch Padeh Poriya Medical Center, Erlangen, Germany.

出版信息

Ir J Med Sci. 2021 Nov;190(4):1271-1274. doi: 10.1007/s11845-020-02452-8. Epub 2021 Jan 6.

Abstract

SARS-CoV-2, causing the lethal disease COVid-19, is a public health emergency in the 2020 global pandemic. The outbreak and fast spreading of SARS-CoV-2 have a high morbidity and mortality specifically in elder patients with chronic diseases such as diabetes mellitus, arterial hypertension, chronic kidney disease, and organ transplanted patients with immunosuppressive therapy. Preliminary results support different treatments such as chloroquine and convalescent plasma infusion in severe cases, with good outcome. On the other hand, the efficacy of supplementation with active vitamin D, an immunomodulator hormone with antiinflammatory and antimicrobial effects, is unproven. A recent study reported that vitamin D attains antiviral effects, via blocking viral replication directly. SARS-CoV-2 primarily uses the immune evasion process during infection via the envelope spike glycoprotein, which is followed by a cytokine storm, causing severe acute respiratory disease syndrome and death. SARS-CoV-2, by using the well-known angiotensin-converting enzyme 2 by the protein spike, as the host receptor to enter into alveolar, myocardial, and renal epithelial cells, can be disrupted by vitamin D. However, the correlation between vitamin D levels and COVID-19 deaths in previous studies was insignificant. Retrospective studies demonstrated a correlation between vitamin D status and COVID-19 severity and mortality, while other studies did not find this correlation. Studies have shown that, vitamin D reduces the risk of acute viral respiratory tract infections and pneumonia via direct inhibition of viral replication, antiinflammatory and immunomodulatory effects. The data available today regarding the beneficial protective effect of vitamin D is unclear and with conflicting results. Large randomized control trials are necessary to test this hypothesis. In this review, we will explain the cross talk between the active vitamin D and the angiotensin-converting enzyme 2, and summarize the data from the literature.

摘要

SARS-CoV-2 导致致命疾病 COVID-19,是 2020 年全球大流行中的公共卫生紧急事件。SARS-CoV-2 的爆发和快速传播具有很高的发病率和死亡率,特别是在患有糖尿病、动脉高血压、慢性肾脏病和接受免疫抑制治疗的器官移植等慢性病的老年患者中。初步结果支持在重症病例中使用氯喹和恢复期血浆输注等不同治疗方法,效果良好。另一方面,补充活性维生素 D 的疗效尚未得到证实,维生素 D 是一种具有抗炎和抗菌作用的免疫调节剂激素。最近的一项研究报告称,维生素 D 通过直接阻断病毒复制发挥抗病毒作用。SARS-CoV-2 在感染过程中主要通过包膜刺突糖蛋白进行免疫逃逸,随后引发细胞因子风暴,导致严重急性呼吸窘迫综合征和死亡。SARS-CoV-2 通过其蛋白刺突上众所周知的血管紧张素转换酶 2,作为宿主受体进入肺泡、心肌和肾上皮细胞,可以被维生素 D 破坏。然而,先前的研究中维生素 D 水平与 COVID-19 死亡之间的相关性并不显著。回顾性研究表明,维生素 D 状态与 COVID-19 的严重程度和死亡率之间存在相关性,而其他研究则没有发现这种相关性。研究表明,维生素 D 通过直接抑制病毒复制、抗炎和免疫调节作用,降低急性病毒性呼吸道感染和肺炎的风险。目前关于维生素 D 有益保护作用的数据尚不清楚,且结果存在矛盾。需要进行大型随机对照试验来验证这一假设。在这篇综述中,我们将解释活性维生素 D 和血管紧张素转换酶 2 之间的相互作用,并总结文献中的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70db/7787599/03e750b05381/11845_2020_2452_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验